BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 22507880)

  • 1. The structure of the von Willebrand factor is not altered in patients with colorectal carcinoma.
    Weiss DR; Eiche C; Hupke C; Schellerer VS; Keller AK; Strasser EF; Ringwald J; Zimmermann R; Eckstein R
    Colorectal Dis; 2012 Dec; 14(12):1500-6. PubMed ID: 22507880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between ABO blood groups and von Willebrand factor, ADAMTS13 and factor VIII in patients undergoing hemodialysis.
    Rios DR; Fernandes AP; Figueiredo RC; Guimarães DA; Ferreira CN; Simões E Silva AC; Carvalho MG; Gomes KB; Dusse LM
    J Thromb Thrombolysis; 2012 May; 33(4):416-21. PubMed ID: 22466813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in von Willebrand factor-cleaving protease (ADAMTS-13) in patients with aortic stenosis undergoing valve replacement or balloon valvuloplasty.
    Bander J; Elmariah S; Aledort LM; Dlott J; Stelzer P; Halperin JL; Kini AS; Sharma SK
    Thromb Haemost; 2012 Jul; 108(1):86-93. PubMed ID: 22627470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complex changes in von Willebrand factor-associated parameters are acquired during uncomplicated pregnancy.
    Drury-Stewart DN; Lannert KW; Chung DW; Teramura GT; Zimring JC; Konkle BA; Gammill HS; Johnsen JM
    PLoS One; 2014; 9(11):e112935. PubMed ID: 25409031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deficient activity of von Willebrand's factor-cleaving protease in patients with disseminated malignancies.
    Oleksowicz L; Bhagwati N; DeLeon-Fernandez M
    Cancer Res; 1999 May; 59(9):2244-50. PubMed ID: 10232615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased plasma von Willebrand factor antigen levels but normal von Willebrand factor cleaving protease (ADAMTS13) activity in preeclampsia.
    Molvarec A; Rigó J; Bõze T; Derzsy Z; Cervenak L; Makó V; Gombos T; Udvardy ML; Hársfalvi J; Prohászka Z
    Thromb Haemost; 2009 Feb; 101(2):305-11. PubMed ID: 19190814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relationship between ABO groups and subgroups, factor VIII and von Willebrand factor.
    Sousa NC; Anicchino-Bizzacchi JM; Locatelli MF; Castro V; Barjas-Castro ML
    Haematologica; 2007 Feb; 92(2):236-9. PubMed ID: 17296574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactions of von Willebrand factor and ADAMTS13 in von Willebrand disease and thrombotic thrombocytopenic purpura.
    Budde U; Schneppenheim R
    Hamostaseologie; 2014; 34(3):215-25. PubMed ID: 25010251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Left atrial blood stasis and Von Willebrand factor-ADAMTS13 homeostasis in atrial fibrillation.
    Ammash N; Konik EA; McBane RD; Chen D; Tange JI; Grill DE; Herges RM; McLeod TG; Friedman PA; Wysokinski WE
    Arterioscler Thromb Vasc Biol; 2011 Nov; 31(11):2760-6. PubMed ID: 21852562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute myocardial infarction as a systemic prothrombotic condition evidenced by increased von Willebrand factor protein over ADAMTS13 activity in coronary and systemic circulation.
    Horii M; Uemura S; Uemura M; Matsumoto M; Ishizashi H; Imagawa K; Iwama H; Takeda Y; Kawata H; Nakajima T; Fujimura Y; Saito Y
    Heart Vessels; 2008 Sep; 23(5):301-7. PubMed ID: 18810578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma levels of von Willebrand factor regulate ADAMTS-13, its major cleaving protease.
    Mannucci PM; Capoferri C; Canciani MT
    Br J Haematol; 2004 Jul; 126(2):213-8. PubMed ID: 15238142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new variant of von Willebrand's disease (type I Padua): doublet-organized plasma von Willebrand factor oligomers in the presence of all size multimers.
    Casonato A; Pontara E; Dannhäuser D; Bertomoro A; Sartori MT; Girolami A
    Haematologia (Budap); 1994; 26(2):97-109. PubMed ID: 7890268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased von Willebrand factor over decreased ADAMTS13 activity may contribute to the development of liver disturbance and multiorgan failure in patients with alcoholic hepatitis.
    Matsuyama T; Uemura M; Ishikawa M; Matsumoto M; Ishizashi H; Kato S; Morioka C; Fujimoto M; Kojima H; Yoshiji H; Takimura C; Fujimura Y; Fukui H
    Alcohol Clin Exp Res; 2007 Jan; 31(1 Suppl):S27-35. PubMed ID: 17331163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymorphisms and mutations in vWF and ADAMTS13 genes and their correlation with plasma levels of FVIII and vWF in patients with deep venous thrombosis.
    Bittar LF; de Paula EV; Mello TB; Siqueira LH; Orsi FL; Annichino-Bizzacchi JM
    Clin Appl Thromb Hemost; 2011 Oct; 17(5):514-8. PubMed ID: 20682599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered von Willebrand factor subunit proteolysis and multimer processing associated with the Cys2362Phe mutation in the B2 domain.
    Casonato A; De Marco L; Gallinaro L; Sztukowska M; Mazzuccato M; Battiston M; Pagnan A; Ruggeri ZM
    Thromb Haemost; 2007 Apr; 97(4):527-33. PubMed ID: 17393013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in von Willebrand factor and ADAMTS-13 in patients following arthroplasty.
    Liu L; Ling J; Ma Z; Yuan Q; Pan J; Yang H
    Mol Med Rep; 2015 Apr; 11(4):3015-20. PubMed ID: 25482054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The association of von Willebrand factor and von Willebrand factor-cleaving protease in systemic lupus erythematosus].
    Lu GY; Guo XF; Wang ZY; Bai X; Su J; Ruan CG
    Zhonghua Nei Ke Za Zhi; 2006 Jan; 45(1):42-4. PubMed ID: 16624087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Shear-Dependent Interactions of von Willebrand Factor with Factor VIII and Protease ADAMTS 13 Demonstrated at a Single Molecule Level by Atomic Force Microscopy.
    Bonazza K; Rottensteiner H; Schrenk G; Frank J; Allmaier G; Turecek PL; Scheiflinger F; Friedbacher G
    Anal Chem; 2015 Oct; 87(20):10299-305. PubMed ID: 26369694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of von Willebrand factor and ADAMTS-13 antigen and activity levels in sickle cell disease patients in Kuwait.
    Al-Awadhi A; Adekile A; Marouf R
    J Thromb Thrombolysis; 2017 Jan; 43(1):117-123. PubMed ID: 27613177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in plasma von Willebrand factor-cleaving protease (ADAMTS13) levels in patients with unstable angina.
    Fuchigami S; Kaikita K; Soejima K; Matsukawa M; Honda T; Tsujita K; Nagayoshi Y; Kojima S; Nakagaki T; Sugiyama S; Ogawa H
    Thromb Res; 2008; 122(5):618-23. PubMed ID: 18295305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.